Avanos Medical (AVNS) Share-based Compensation (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Avanos Medical | 1.17 Bn | 1.10 Bn | 94.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 208.33% |
| Dec 31, 2025 | -65.71% |
| Sep 30, 2025 | -14.63% |
| Jun 30, 2025 | 7.89% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 46.15% |
| Sep 30, 2024 | -31.58% |
| Jun 30, 2024 | 5.56% |
| Mar 31, 2024 | -10.00% |
| Dec 31, 2023 | 2.56% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | -2.50% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | -2.44% |
| Sep 30, 2022 | 2.50% |
| Jun 30, 2022 | 5.26% |
| Mar 31, 2022 | 26.67% |
| Dec 31, 2021 | -14.29% |
| Sep 30, 2021 | -2.78% |
| Jun 30, 2021 | 16.13% |
| Mar 31, 2021 | -3.13% |
| Dec 31, 2020 | -5.88% |
| Sep 30, 2020 | 13.33% |
| Jun 30, 2020 | 20.00% |
| Mar 31, 2020 | 47.06% |
| Dec 31, 2019 | -39.29% |
| Sep 30, 2019 | 55.56% |
| Jun 30, 2019 | -57.14% |
| Mar 31, 2019 | 68.00% |
| Dec 31, 2018 | 4.17% |
| Sep 30, 2018 | 14.29% |
| Jun 30, 2018 | -40.00% |
| Mar 31, 2018 | 400.00% |
| Dec 31, 2017 | -66.67% |
| Sep 30, 2017 | -61.11% |
| Jun 30, 2017 | 22.73% |
| Mar 31, 2017 | 76.00% |
| Dec 31, 2016 | -16.67% |
| Sep 30, 2016 | -45.45% |
| Jun 30, 2016 | 44.74% |
| Sep 30, 2015 | -35.85% |
| Jun 30, 2015 | -1.85% |
| Mar 31, 2015 | 92.86% |
| Dec 31, 2014 | -6.67% |
| Sep 30, 2014 | 114.29% |
| Jun 30, 2014 | 100.00% |
| Mar 31, 2014 | -46.15% |